Kaelber, David C.

Clinical practice guideline for screening and management of high blood pressure in children and adolescents

Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., Blowey, D., Carroll, A. E., Daniels, S. R., de Ferranti, S. D., Dionne, J. M., Falkner, B., Flinn, S. K., et al. (2017) · Pediatrics

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 3,651

COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States

Wang, Q. Q., Kaelber, D. C., Xu, R., & Volkow, N. D. (2021) · Molecular Psychiatry

COVID-19 Clinical Research StudiesOpioid Use Disorder Treatment

Cited by 634

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes

Wang, L., Xu, R., Kaelber, D. C., & Berger, N. A. (2024) · JAMA Network Open

Metabolism, Diabetes, and CancerDiabetes Treatment and Management

Cited by 304

Association of semaglutide with risk of suicidal ideation in a real-world cohort

Wang, W., Volkow, N. D., Berger, N. A., Davis, P. B., Kaelber, D. C., & Xu, R. (2024) · Nature Medicine

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 248

Health information exchange and patient safety

Kaelber, D. C., & Bates, D. W. (2007) · Journal of Biomedical Informatics

Electronic Health Records SystemsPatient Safety and Medication Errors

Cited by 206

Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US

Wang, W., Wang, Q., Qi, X., Gurney, M., Perry, G., Volkow, N. D., Davis, P. B., Kaelber, D. C., & Xu, R. (2024) · Alzheimer's & Dementia

Diabetes Treatment and ManagementDementia and Cognitive Impairment Research

Cited by 180

Association of COVID-19 with New-Onset Alzheimer’s Disease

Wang, L., Davis, P. B., Volkow, N. D., Berger, N. A., Kaelber, D. C., & Xu, R. (2022) · Journal of Alzheimer's Disease

Long-Term Effects of COVID-19Dementia and Cognitive Impairment Research

Cited by 178

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis

Zhou, M., Xu, R., Kaelber, D. C., & Gurney, M. E. (2020) · PLOS ONE

Rheumatoid Arthritis Research and TherapiesDementia and Cognitive Impairment Research

Cited by 157

The Cosmos Collaborative: A Vendor-Facilitated Electronic Health Record Data Aggregation Platform

Tarabichi, Y., Frees, A., Honeywell, S., Huang, C., Naidech, A. M., Moore, J. H., & Kaelber, D. C. (2021) · ACI Open

Electronic Health Records SystemsMedical Coding and Health Information

Cited by 139

The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy

Abbass, N. J., Nahlawi, R., Shaia, J. K., Allan, K. C., Kaelber, D. C., Talcott, K. E., & Singh, R. P. (2025) · American Journal of Ophthalmology

Diabetes Treatment and ManagementDrug-Induced Ocular Toxicity

Cited by 78

Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes: Target Trial Emulation Using Real-World Data

Wang, W., Volkow, N. D., Berger, N. A., Davis, P. B., Kaelber, D. C., & Xu, R. (2024) · Annals of Internal Medicine

Smoking Behavior and CessationDiabetes Treatment and Management

Cited by 72

Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder

Wang, W., Volkow, N. D., Wang, Q., Berger, N. A., Davis, P. B., Kaelber, D. C., & Xu, R. (2024) · JAMA Network Open

Opioid Use Disorder TreatmentDiabetes Treatment and Management

Cited by 63

Glucagon-like Peptide-1 receptor agonist impact on chronic ocular disease including age-related macular degeneration

Allan, K. C., Joo, J. H., Kim, S., Shaia, J., Kaelber, D. C., Singh, R., Talcott, K. E., & Rachitskaya, A. V. (2025) · Ophthalmology

Retinal Diseases and TreatmentsGlaucoma and retinal disorders

Cited by 54

Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data

Wang, L., Wang, Q., Li, L., Kaelber, D. C., & Xu, R. (2025) · JNCI: Journal of the National Cancer Institute

Diabetes Treatment and ManagementPancreatic and Hepatic Oncology Research

Cited by 53

Semaglutide or tirzepatide and optic nerve and visual pathway disorders in type 2 diabetes

Wang, L., Volkow, N. D., Kaelber, D. C., & Xu, R. (2025) · JAMA Network Open

Diabetes Treatment and ManagementDrug-Induced Ocular Toxicity

Cited by 51

The Value of Provider-to-Provider Telehealth

Pan, E., Cusack, C., Hook, J., Vincent, A., Kaelber, D. C., Bates, D. W., & Middleton, B. (2008) · Telemedicine and e-Health

Telemedicine and Telehealth ImplementationHealth Systems, Economic Evaluations, Quality of Life

Cited by 46

Code Status Reconciliation to Improve Identification and Documentation of Code Status in Electronic Health Records

Jain, V. G., Greco, P. J., & Kaelber, D. C. (2017) · Applied Clinical Informatics

Electronic Health Records SystemsPalliative Care and End-of-Life Issues

Cited by 10

Major adverse cardiovascular events (MACE) in cancer patients treated with tirzepatide compared to GLP-1 receptor agonists: A target trial emulation using real-world data.

Ashruf, O., Mushtaq, A., Lin, C. (.-T., Volk, M., Orozco, Z., Hundal, J., Safdar, A., Thompson, C., Karimi, S., Jain, A. G., et al. (2025) · Journal of Clinical Oncology

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 4